However, in the group receiving intravenous insulin, eight participants experienced episodes of severe hypoglycemia (defined as blood glucose < 2.2 mM), versus only one participant in the subcutaneous group (p = 0.010). This evidence concerns the gene INS and Hypoglycemia.